Protective Effects of Follicle-stimulating Hormone Inhibitor on Alveolar Bone Loss Resulting from Experimental Periapical Lesions in Ovariectomized Rats

Journal of Endodontics

Volumn 36, Issue 4, 2010, Pages 658-663

  Liu, Shengbo ^a   Cheng, Yong ^a   Xu, Wangmin ^b   Bian, Zhuan ^a  

^a WUHAN UNIVERSITY   (China)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Alveolar bone loss; follicle stimulating hormone (FSH); leuprorelin; osteoclast; periapical lesions

Indexed keywords

ESTROGEN; FERTILITY PROMOTING AGENT; FOLLITROPIN; FOLLITROPIN RECEPTOR; LEUPRORELIN; LUTEINIZING HORMONE;

ALVEOLAR BONE LOSS; ANIMAL; ARTICLE; BLOOD; DRUG ANTAGONISM; DRUG EFFECT; ENDODONTICS; FEMALE; IMMUNOHISTOCHEMISTRY; OSTEOCLAST; OVARIECTOMY; RADIOGRAPHY; RANDOMIZATION; RAT; SPRAGUE DAWLEY RAT; TOOTH PERIAPICAL DISEASE;

ALVEOLAR BONE LOSS; ANIMALS; DENTAL PULP EXPOSURE; ESTROGENS; FEMALE; FERTILITY AGENTS, FEMALE; FOLLICLE STIMULATING HORMONE; IMMUNOHISTOCHEMISTRY; LEUPROLIDE; LUTEINIZING HORMONE; OSTEOCLASTS; OVARIECTOMY; PERIAPICAL PERIODONTITIS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, FSH;

EID: 77949437004     PISSN: 00992399     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joen.2010.01.011     Document Type: Article

References (24)

1. Sun L., Peng Y., Sharrow A.C., et al. FSH directly regulates bone mass. Cell 125 (2006) 247-260
2. Martin T.J., and Gaddy D. Bone loss goes beyond estrogen. Nat Med 12 (2006) 612-613
3. Zaidi M., Blair H.C., Iqbal J., et al. Proresorption actions of FSH and bone loss. Ann N Y Acad Sci 1116 (2007) 376-382
4. Smith M.R., McGovern F.J., Zietman A.L., et al. Pamidronate to prevent bone loss during androgen deprivation therapy for prostate cancer. N Engl J Med 345 (2001) 948-955
5. Prior J.C. FSH and bone: important physiology or not?. Trends Mol Med 13 (2006) 1-3
6. Gilles J.A., Carnes D.L., Dallas M.R., et al. Oral bone loss is increased in ovariectomized rats. J Endod 23 (1997) 419-422
7. Kawamoto S., and Nagaoka E. The effect of oestrogen deficiency on the alveolar bone resorption caused by traumatic occlusion. J Oral Rehabil 27 (2000) 587-594
8. Kawamoto S., Ejiri S., Nagaoka E., et al. Effects of oestrogen deficiency on osteoclastogenesis in the rat periodontium. Arch Oral Biol 47 (2002) 67-73
9. Liu SB, Cheng Y, Fan MW, et al. FSH aggravates periodontitis-related bone loss in ovariectomized rats. [published online ahead of print February 5, 2010] J Dent Res doi:10.1177/0022034509358822.
10. Chrisp P., and Sorkin E.M. Leuprorelin: A review of its pharmacology and therapeutic use in prostatic disorders. Drugs Aging 1 (1991) 487-509
11. Abouelfadel Z., and Crawford E.D. Leuprorelin depot injection: patient considerations in the management of prostatic cancer. Ther Clin Risk Manag 4 (2008) 513-526
12. Metzger Z., Klein H., Klein A., et al. Periapical lesion development in rats inhibited by dexamethasone. J Endod 28 (2002) 643-645
13. Xiong H., Peng B., Wei L., et al. Effect of estrogen-deficiency state and alendronate therapy on bone loss resulting from experimental periapical lesions on rats. J Endod 33 (2007) 1304-1308
14. 1 in induced rat periapical lesions. J Endod 26 (2000) 335-340
15. Balto K., Mu{combining double acute accent}ller R., Carrington D.C., Dobeck J., and Stashenko P. Quantification of periapical bone destruction in mice by Micro-computed Tomography. J Dent Res 79 (2000) 35-40
16. Huang G.T.J., Do M., Wingard M., et al. Effect of interleukin-6 deficiency on the formation of periapical lesions after pulp exposure in mice. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 92 (2001) 83-88
17. Minkin C. Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteockast function. Calcif Tissue Int 34 (1982) 285-290
18. Zhang J., Peng B., and Chen X. Expressions of nuclear factor κB, inducible nitric oxide synthase, and vascular endothelial growth factor in adenoid cystic carcinoma of salivary glands: correlations with the angiogenesis and clinical outcome. Clin Cancer Res 11 (2005) 7334-7343
19. Zhang X., and Peng B. Immunolocalization of receptor activator of NF kappa B ligand in rat periapical lesions. J Endod 31 (2005) 574-577
20. Iqbal J., Sun L., Kumar R., et al. Follicle-stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation. Proc Natl Acad Sci U S A 103 (2006) 14925-14930
21. Razmus T.F. Caries, periodontal disease, and periapical changes. Dent Clin North Am 38 (1994) 13-31
22. Duarte P.M., Goncalves P.F., Sallum A.W., et al. Effect of an estrogen-deficient state and its therapy on bone loss resulting from an experimental periodontitis in rats. J Periodont Res 39 (2004) 107-110
23. Nociti Jr. F.H., Sallum A.W., Duarte P.M., et al. Effect of estrogen replacement and calcitonin therapies on bone around titanium implants placed in ovariectomized rats: a histometric study. Int J Oral Maxillofac Implants 17 (2002) 786-792
24. Duarte P.M., Goncalves P.F., Casati M.Z., et al. Estrogen and alendronate therapies may prevent the influence of estrogen deficiency on the tooth-supporting alveolar bone: a histometric study in rats. J Periodont Res 41 (2006) 541-546